Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. 483
  6. /
  7. Resilience US, Inc.
483
•Resilience US, Inc.•December 23, 2009

Resilience US, Inc. – FDA 483, Dec 23, 2009

Record Details

An FDA inspection of Amylin Pharmaceuticals Inc., a pharmaceutical manufacturer located at 8814 Trade Port Dr, West Chester, OH 45071, was conducted from December 7 to December 23, 2009. The inspection revealed ten observations regarding the firm's compliance with manufacturing and quality control regulations.

Key observations include: 1. **Microbiological Contamination Prevention:** Procedures to prevent microbiological contamination of sterile drug products are not established and followed. Specifically, media fills simulating the commercial automated inspection process (including vibrator/shaker table) have not been completed, with all ten performed media fills undergoing manual visual inspection. 2. **Laboratory Control Documentation:** Established laboratory control mechanisms are not documented at the time of performance. A contractor with a cast on his arm was signed off as having adequately demonstrated gowning procedures for aseptic area entry, despite it being impossible, and Quality Control failed to review these records or initiate an investigation. 3. **Production and Process Control Procedures:** Written production and process control procedures are not followed. There is no SOP addressing who can disable alarms, under what circumstances, or who is responsible for such decisions. An AIT-21201 alarm (detecting high Total Organic Carbon in hot water-for-injection distribution loop) was disabled by the facilities department at the instruction of the QA Director without a governing SOP. 4. **In-process Material Testing:** In

Company
Resilience US, Inc.
Inspection date
December 23, 2009
Product type
Drugs
Office
Cincinnati District Office
People
  • Cherrie A. Zachary
  • Elizabeth Loreaux
  • Anna M. Brannen
  • Nicholas L. Paulin
View Company Profile

ID · 692c58e3-a3a2-4a48-9047-947fe1547fd4

Violation Codes10
21 CFR 211.113(b)21 CFR 211.19221 CFR 211.194(a)21 CFR 211.100(b)21 CFR 211.67(b)21 CFR 211.160(a)21 CFR 211.110(a)21 CFR 211.25(a)21 CFR 211.18021 CFR 211.182

Full citation text and observation details available on the Dashboard.

Other documents for Resilience US, Inc.
  • 483 - 2025-01-21January 21, 2025
  • 483 - 2022-05-25May 25, 2022
  • 483 - 2019-08-09August 9, 2019

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Resilience US, Inc.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.